Chitosan is extracted from shells of aquatic species such as lobsters, shrimps, and crabs and is derived from chitin. Chitosan is widely used in dietary supplements as it inhibits lipid absorption in the gastrointestinal tract. It is also used in various healthcare applications due to its biodegradability and biocompatibility properties. It is used in hemostatic dressing in order to treat wounds owing to its anticoagulant properties.
Market Dynamics
Chitosan is also used in dental filler materials which is further projected to bolster the market growth. Chitosan is gaining traction in the healthcare industry where it is used in the manufacturing of bio-based products for wound care management.
Increasing demand for chitosan from dental applications is augmenting the market growth. It is used to manufacture mouthwashes, toothpaste, and chewing gums owing to its anti-decay and anti-plaque properties. The growing demand for chitosan as a flocculent in the water treatment industry is primarily fueling the market growth of chitosan.
Key features of the study:
- This report provides in-depth analysis of the global chitosan market and provides market size (US$ Billion & Tons) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by key players
- This study also provides an impact analysis of the Coronavirus (Covid-19) pandemic on the global chitosan market.
- It profiles key players in the global chitosan market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study are GTC Bio Corporation, KitoZyme S.A., Biothera, Golden-Shell Pharmaceuticals Co., Ltd., FMC Health and Nutrition, Panvo Organics Pvt. Ltd., Heppe Medical Chitosan GmbH, Primex ehf, PT Biotech Surindo, Xianju Tengwang Chitosan Factory
- Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology upgradation, market expansion, and marketing tactics
- The global chitosan market report caters to various stakeholders in this industry including investors, suppliers, global chitosan manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chitosan market
Detailed Segmentation:
- Global Chitosan Market, By Application:
- Water Treatment
- Biomedicine & Pharmaceuticals
- Industrial
- Food & Beverage
- Cosmetics
- Agrochemicals
- Others
- Global Chitosan Market, By Region:
- North America
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Company Profiles
- GTC Bio Corporation
- KitoZyme S.A
- Biothera
- Golden-Shell Pharmaceutical Co, Ltd.
- FMC Health and Nutrition
- Panvo Organics Pvt. Ltd.
- Heppe Medical Chitosan GmbH
- Primex ehf
- PT Biotech Surindo
- Xianju Tengwang Chitosan Factory
